Additionally, Abraham et al. demonstrated that intratumoral injections of small interfering RNAs targeting mouse CSF-1 resulted in significant suppression of tumor growth in SK-N-AS and SK-N-DZ neuroblastoma xenografts, accompanied by decreased TAM infiltration [168]. The gene discussed is CSF1; the disease is neuroblastoma.